Table of Contents:
  • Tumor vasculature : a target for anticancer therapies
  • Abnormal microvasculature and defective microcirculatory function in solid tumors
  • The role of microvasculature in metastasis formation
  • Development of agents that selectively disrupt tumor vasculature : a historical perspective
  • Morphologic manifestations of vascular-disrupting agents in preclinical models
  • Molecular recognition of the colchicine binding site as a design paradigm for the discovery and development of vascular disrupting agents
  • Combined modality approaches using vascular-disrupting agents
  • Vascular-targeting therapies and hyperthermia
  • Flavones and xanthenones as vascular-disrupting agents
  • Targeting inside-out phospholipids on tumor blood vessels in pancreatic cancer
  • Cadherin antagonists as vascular-targeting agents
  • Alphastatin : a pluripotent inhibitor of activated endothelial cells
  • Cationic lipid complexes to target tumor endothelium
  • Development of vascular-targeting cancer gene therapy
  • Vascular-disrupting strategies combined with bacterial spores targeting hypoxic regions of solid tumors
  • Imaging the effects of vascular-targeting agents
  • Clinical progress in tumor vasculature-disrupting therapies
  • Use of vascular-disrupting agents in non-oncology indications